Welch & Forbes LLC Laboratory Corp Of America Holdings Transaction History

Welch & Forbes LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$209.01 - $232.56 $82,140 - $91,396	-393 Reduced 15.04%	2,220 $484,000
Q4 2023 Feb 06, 2024	SELL	$197.69 - $227.29 $27,478 - $31,593	-139 Reduced 5.05%	2,613 $593,000
Q3 2023 Nov 02, 2023	BUY	$201.05 - $221.7 $2,211 - $2,438	11 Added 0.4%	2,752 $553,000
Q2 2023 Jul 28, 2023	SELL	$211.93 - $241.33 $4,662 - $5,309	-22 Reduced 0.8%	2,741 $661,000
Q1 2023 Apr 14, 2023	SELL	$213.32 - $257.83 $20,052 - $24,236	-94 Reduced 3.29%	2,763 $633,000
Q4 2022 Feb 02, 2023	BUY	$203.72 - $248.97 $5,296 - $6,473	26 Added 0.92%	2,857 $672,000
Q3 2022 Oct 28, 2022	BUY	$204.81 - $262.19 $12,698 - $16,255	62 Added 2.24%	2,831 $580,000
Q2 2022 Jul 22, 2022	BUY	$213.86 - $277.87 $149,702 - $194,509	700 Added 33.83%	2,769 $649,000
Q1 2022 Apr 25, 2022	BUY	$259.82 - $298.18 $537,567 - $616,934	2,069 New	2,069 $546,000

113

2.32M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.4B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

Stay updated on Welch & Forbes LLC with notifications on news.